Selected research
Industry Research
Needle-free Hypodermic Syringe Industry Research Report 2026
Market perspective
The global Needle-free Hypodermic Syringe market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Needle-free Hypodermic Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Needle-free Hypodermic Syringe is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Needle-free Hypodermic Syringe is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Needle-free Hypodermic Syringe include Zoetis, Aptar Pharma, Veloxis Pharmaceuticals, SHL Medical, Portal Instruments, PharmaJet, PenJet, Oval Medical Technologies and Lifecare AS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Needle-free Hypodermic Syringe market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Needle-free Hypodermic Syringe Market by Company
Zoetis
Aptar Pharma
Veloxis Pharmaceuticals
SHL Medical
Portal Instruments
PharmaJet
PenJet
Oval Medical Technologies
Lifecare AS
Enable Injections
Crossject
Antares Pharma
Needle-free Hypodermic Syringe Segment by Type
Electric Needle-Free Injector
Hydraulic Needle-Free Injector
Needle-free Hypodermic Syringe Segment by Application
Hospital
Specialist Clinic
Others
Needle-free Hypodermic Syringe Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-free Hypodermic Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Needle-free Hypodermic Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-free Hypodermic Syringe.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Needle-free Hypodermic Syringe manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Needle-free Hypodermic Syringe by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Needle-free Hypodermic Syringe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Electric Needle-Free Injector
- Hydraulic Needle-Free Injector
Applications
- Hospital
- Specialist Clinic
- Others
Companies covered
- Zoetis
- Aptar Pharma
- Veloxis Pharmaceuticals
- SHL Medical
- Portal Instruments
- PharmaJet
- PenJet
- Oval Medical Technologies
- Lifecare AS
- Enable Injections
- Crossject
- Antares Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Needle-free Hypodermic Syringe Market Size (2021-2032)
- 2.2.2 Global Needle-free Hypodermic Syringe Sales (2021-2032)
- 2.2.3 Global Needle-free Hypodermic Syringe Market Average Price (2021-2032)
- 2.3 Needle-free Hypodermic Syringe by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Electric Needle-Free Injector
- 2.3.3 Hydraulic Needle-Free Injector
- 2.4 Needle-free Hypodermic Syringe by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Specialist Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Needle-free Hypodermic Syringe Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Needle-free Hypodermic Syringe Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Needle-free Hypodermic Syringe Revenue of Manufacturers (2021-2026)
- 3.4 Global Needle-free Hypodermic Syringe Average Price by Manufacturers (2021-2026)
- 3.5 Global Needle-free Hypodermic Syringe Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Needle-free Hypodermic Syringe, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Needle-free Hypodermic Syringe, Product Type & Application
- 3.8 Global Manufacturers of Needle-free Hypodermic Syringe, Established Date
- 3.9 Global Needle-free Hypodermic Syringe Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Needle-free Hypodermic Syringe Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Aptar Pharma
- 4.2.1 Aptar Pharma Company Information
- 4.2.2 Aptar Pharma Business Overview
- 4.2.3 Aptar Pharma Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Aptar Pharma Needle-free Hypodermic Syringe Product Portfolio
- 4.2.5 Aptar Pharma Recent Developments
- 4.3 Veloxis Pharmaceuticals
- 4.3.1 Veloxis Pharmaceuticals Company Information
- 4.3.2 Veloxis Pharmaceuticals Business Overview
- 4.3.3 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolio
- 4.3.5 Veloxis Pharmaceuticals Recent Developments
- 4.4 SHL Medical
- 4.4.1 SHL Medical Company Information
- 4.4.2 SHL Medical Business Overview
- 4.4.3 SHL Medical Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 SHL Medical Needle-free Hypodermic Syringe Product Portfolio
- 4.4.5 SHL Medical Recent Developments
- 4.5 Portal Instruments
- 4.5.1 Portal Instruments Company Information
- 4.5.2 Portal Instruments Business Overview
- 4.5.3 Portal Instruments Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Portal Instruments Needle-free Hypodermic Syringe Product Portfolio
- 4.5.5 Portal Instruments Recent Developments
- 4.6 PharmaJet
- 4.6.1 PharmaJet Company Information
- 4.6.2 PharmaJet Business Overview
- 4.6.3 PharmaJet Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PharmaJet Needle-free Hypodermic Syringe Product Portfolio
- 4.6.5 PharmaJet Recent Developments
- 4.7 PenJet
- 4.7.1 PenJet Company Information
- 4.7.2 PenJet Business Overview
- 4.7.3 PenJet Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PenJet Needle-free Hypodermic Syringe Product Portfolio
- 4.7.5 PenJet Recent Developments
- 4.8 Oval Medical Technologies
- 4.8.1 Oval Medical Technologies Company Information
- 4.8.2 Oval Medical Technologies Business Overview
- 4.8.3 Oval Medical Technologies Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolio
- 4.8.5 Oval Medical Technologies Recent Developments
- 4.9 Lifecare AS
- 4.9.1 Lifecare AS Company Information
- 4.9.2 Lifecare AS Business Overview
- 4.9.3 Lifecare AS Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lifecare AS Needle-free Hypodermic Syringe Product Portfolio
- 4.9.5 Lifecare AS Recent Developments
- 4.10 Enable Injections
- 4.10.1 Enable Injections Company Information
- 4.10.2 Enable Injections Business Overview
- 4.10.3 Enable Injections Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Enable Injections Needle-free Hypodermic Syringe Product Portfolio
- 4.10.5 Enable Injections Recent Developments
- 4.11 Crossject
- 4.11.1 Crossject Company Information
- 4.11.2 Crossject Business Overview
- 4.11.3 Crossject Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Crossject Needle-free Hypodermic Syringe Product Portfolio
- 4.11.5 Crossject Recent Developments
- 4.12 Antares Pharma
- 4.12.1 Antares Pharma Company Information
- 4.12.2 Antares Pharma Business Overview
- 4.12.3 Antares Pharma Needle-free Hypodermic Syringe Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Antares Pharma Needle-free Hypodermic Syringe Product Portfolio
- 4.12.5 Antares Pharma Recent Developments
5 Global Needle-free Hypodermic Syringe Market Scenario by Region
- 5.1 Global Needle-free Hypodermic Syringe Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Needle-free Hypodermic Syringe Sales by Region: 2021-2032
- 5.2.1 Global Needle-free Hypodermic Syringe Sales by Region: 2021-2026
- 5.2.2 Global Needle-free Hypodermic Syringe Sales by Region: 2027-2032
- 5.3 Global Needle-free Hypodermic Syringe Revenue by Region: 2021-2032
- 5.3.1 Global Needle-free Hypodermic Syringe Revenue by Region: 2021-2026
- 5.3.2 Global Needle-free Hypodermic Syringe Revenue by Region: 2027-2032
- 5.4 North America Needle-free Hypodermic Syringe Market Facts & Figures by Country
- 5.4.1 North America Needle-free Hypodermic Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Needle-free Hypodermic Syringe Sales by Country (2021-2032)
- 5.4.3 North America Needle-free Hypodermic Syringe Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Needle-free Hypodermic Syringe Market Facts & Figures by Country
- 5.5.1 Europe Needle-free Hypodermic Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Needle-free Hypodermic Syringe Sales by Country (2021-2032)
- 5.5.3 Europe Needle-free Hypodermic Syringe Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Needle-free Hypodermic Syringe Market Facts & Figures by Country
- 5.6.1 Asia Pacific Needle-free Hypodermic Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Needle-free Hypodermic Syringe Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Needle-free Hypodermic Syringe Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Needle-free Hypodermic Syringe Market Facts & Figures by Country
- 5.7.1 South America Needle-free Hypodermic Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Needle-free Hypodermic Syringe Sales by Country (2021-2032)
- 5.7.3 South America Needle-free Hypodermic Syringe Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Needle-free Hypodermic Syringe Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Needle-free Hypodermic Syringe Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Needle-free Hypodermic Syringe Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Needle-free Hypodermic Syringe Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Needle-free Hypodermic Syringe Sales by Type (2021-2032)
- 6.1.1 Global Needle-free Hypodermic Syringe Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2032)
- 6.2 Global Needle-free Hypodermic Syringe Revenue by Type (2021-2032)
- 6.2.1 Global Needle-free Hypodermic Syringe Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2021-2032)
- 6.3 Global Needle-free Hypodermic Syringe Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Needle-free Hypodermic Syringe Sales by Application (2021-2032)
- 7.1.1 Global Needle-free Hypodermic Syringe Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2032)
- 7.2 Global Needle-free Hypodermic Syringe Revenue by Application (2021-2032)
- 7.2.1 Global Needle-free Hypodermic Syringe Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2021-2032)
- 7.3 Global Needle-free Hypodermic Syringe Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Needle-free Hypodermic Syringe Value Chain Analysis
- 8.1.1 Needle-free Hypodermic Syringe Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Needle-free Hypodermic Syringe Production Mode & Process
- 8.2 Needle-free Hypodermic Syringe Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Needle-free Hypodermic Syringe Distributors
- 8.2.3 Needle-free Hypodermic Syringe Customers
9 Global Needle-free Hypodermic Syringe Analyzing Market Dynamics
- 9.1 Needle-free Hypodermic Syringe Industry Trends
- 9.2 Needle-free Hypodermic Syringe Industry Drivers
- 9.3 Needle-free Hypodermic Syringe Industry Opportunities and Challenges
- 9.4 Needle-free Hypodermic Syringe Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst